ey0020.3-2 | Novel Treatments for Rare Skeletal Disorders | ESPEYB20
VM Breinholt , PH Mygind , ED Christoffersen , Y Zhang , S Ota , R Will Charlton , D Viuff
ey0015.10-25 | Therapy and interventions | ESPEYB15
LC Deeb , H Dulude , CB Guzman , S Zhang , BJ Reiner , CA Piché , S Pradhan , XM Zhang
ey0021.12-6 | Improving T2D Outcomes | ESPEYB21
WT Garvey , JP Frias , AM Jastreboff , CW le Roux , N Sattar , D Aizenberg , H Mao , S Zhang , NN Ahmad , MC Bunck , I Benabbad , XM; SURMOUNT-2 investigators. Zhang
ey0018.4-11 | New Perspectives | ESPEYB18
Lin Y , Cheng C , Wang C , Liang W , Tang C , Tsai L , Chen C , Wu J , Hsieh A , Lee M , Lin T , Liao C , Huang S , Zhang Y , Tsai C , Tsai F
ey0021.6-7 | Clinical and Molecular Insights into SF1 Deficiency | ESPEYB21
GF Del Gobbo , X Wang , M Couse , L Mackay , C Goldsmith , AE Marshall , Y Liang , C Lambert , S Zhang , H Dhillon , C Fanslow , WJ Rowell , Canada Consortium Care4Rare , CR Marshall , KD Kernohan , KM Boycott
ey0020.4-3 | Sexuality, Fertility and Fertility Optimization in DSD | ESPEYB20
K Xia , F Wang , X Lai , L Dong , P Luo , S Zhang , C Yang , H Chen , Y Ma , W Huang , W Ou , Y Li , X Feng , B Yang , C Liu , Z Lei , X Tu , Q Ke , FF Mao , C Deng , AP Xiang